A Study Using Two Oral Chemotherapy Agents for Chronic Lymphocytic Leukemia

NCT00829647 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Unable to enroll

Conditions

Chronic Lymphocytic Leukemia
Leukemia

Interventions

DRUG: dasatinib and lenalidomide

Sponsor

Scripps Health

Collaborators

[object Object]
[object Object]